Marc Coucke trims Mithra Pharmaceuticals stake

By Aidan Gregory
01 Apr 2021

Alychlo, the family investment company of Belgian billionaire Marc Coucke, has reduced its stake in Mithra Pharmaceuticals through a €40m accelerated bookbuild on Wednesday evening.

Launched after the market close, the placing consisted of 1.57m shares, a 3.6% stake. At the €25.20 offer price, investors received a 5.9% discount to the closing price.

The book was well oversubscribed, according to a source close to the deal. The top five investors took 65% ...

Already a subscriber?

Continue reading this article

Try full access to GlobalCapital

Free trial